HIV prevalence amongst injecting drug users in Iran: A systematic review of studies conducted during the decade 1998-2007

International Journal of Drug Policy

Volumn 23, Issue 4, 2012, Pages 271-278

  Rahimi Movaghar, Afarin ^a   Amin Esmaeili, Masoumeh ^a   Haghdoost, Ali Akbar ^b   Sadeghirad, Behnam ^c   Mohraz, Minoo ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Harm reduction; HIV AIDS; Injecting drug use; Iran; Prevalence; Systematic review; Tehran

Indexed keywords

HARM REDUCTION; HEALTH CARE AVAILABILITY; HEALTH CARE QUALITY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; IRAN; PRIORITY JOURNAL; PRISON; SAMPLE SIZE; SCALE UP; SEX DIFFERENCE; SEX RATIO; SHORT SURVEY; SYSTEMATIC REVIEW; WESTERN BLOTTING;

HARM REDUCTION; HIV INFECTIONS; HUMANS; IRAN; PREVALENCE; PRISONS; QUALITY ASSURANCE, HEALTH CARE; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 84863822646     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2011.09.002     Document Type: Short Survey

References (57)

1. Alaei A. The epidemiological status of HIV infection in addicts of Kermanshah. Paper presented at the 14th International Conference on the Reduction of Drug Related Harm 2003.
2. Amini S., Mahmoodabadi A., Lamian S., Joulaie M., Mahmoodi Farahani M. Prevalence of hepatitis G virus (HGV) in high-risk groups and blood donors in Tehran, Iran. Iranian Journal of Public Health 2005, 34(4):41-46.
3. Aminzadeh Z., Aghazadeh Sarhangi K. Seroepidemiology of HIV, syphilis, hepatitis B and C in intravenous drug users at Loghman Hakim hospital. Iranian Journal of Medical Microbiology 2007, 1(3):53-58. (Abstract in English, full text in Persian).
4. Asadi S., Marjani M. Epidemiology and prevalence of infectious diseases in IVDA in Infectious Wards of Shahid Beheshti University of Medical Sciences, 2002-2003. Iranian Journal of Infectious Diseases and Tropical Medicine 2004, 9(25):53-61. (Abstract in English, full text in Persian).
5. Astarki M., Rouhandeh M., Saki M. Assessing the prevalence of HIV, HCV and HBV infections among drug users in an inpatient drug treatment unit of a psychiatric hospital. Paper presented at the 1st National Congress of Infection in Addicts 2008, (in Persian).
6. Azarkar Z., Sharifzadeh G., Miraki M. HBV, HCV and HIV prevalence among south Khorasan prisoners. Journal of Birjand University of Medical Sciences 2007, 2(14):50-55. (Abstract in English, full text in Persian).
7. Bao Y.P., Liu Z.M. Systematic review of HIV and HCV infection among drug users in China. International Journal of STD and AIDS 2009, 20(6):399-405.
8. High coverage sites: HIV prevention among injecting drug users in transitional and developing countries: Case studies. UNAIDS Best Practice Collection 2006, UNAIDS, Geneva. D. Burrows (Ed.).
9. Day C., Nassirimanesh B., Shakeshaft A., Dolan K. Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduction Journal 2006, 3:2.
10. Des Jarlais D.C., Semaan S. HIV prevention for injecting drug users: The first 25 years and counting. Psychosomatic Medicine 2008, 70(5):606-611.
11. Farahbakhsh E., Behzadi E., Behzadi P. Prevalence of AIDS among referal to Dehkhoda Hospital in Qazvin. Paper presented at the 3rd National Epidemiology Congress 2006, (in Persian).
12. Farhoudian A., Amini H., Sharifi V., Basirnia A., Mesgarpour B., Mansouri N., et al. Systematic review of psychiatric disorders among Iranian adult general population. Iranian Journal of Psychiatry 2007, 2(4):137-149.
13. Ghaleaghaei T., Soltani M., Saberinia A. HIV status in a prison in Kerman province, 2001-2005. Paper presented at the 3rd National Epidemiology Congress 2006, (in Persian).
14. Ghanbarzadeh N., Nadjafi Semnani M. A study of HIV and other sexually transmitted infections among female prisoners in Birjand. Journal of Birjand University of Medical Sciences 2006, 13(3):69-75. (Abstract in English, full text in Persian).
15. Haghshenas M.R., Mirmobini S.M., Babamahmoodi F. Survey of the role of prevalence of Tuberculosis and HIV in prisons of Sari township in 1998-1999. Journal of Mazandaran University Medical Sciences 2000, 10(26):33-37. (Abstract in English, full text in Persian).
16. Hajiabdolbaghi M., Razani N., Karami N., Kheirandish P., Mohraz M., Rasoolinejad M., et al. Insights from a survey of sexual behavior among a group of at-risk women in Tehran, Iran, 2006. AIDS Education and Prevention 2007, 19(6):519-530.
17. Imani R., Karimi A., Rouzbahani R., Rouzbahani A. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran. Eastern Mediterranean Health Journal 2008, 14(5):1136-1141.
18. Jahani M.R., Alavian M., Shirzad H., Kabir A., Hajarizadeh B. Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with illegal social behaviour. Sexually Transmitted Infections 2005, 81:181-185.
19. Jahani M.R., Kheirandish P., Hosseini M., Shirzad H., Seyedalinaghi S.A., Karami N., et al. HIV seroconversion among injection drug users in detention, Tehran, Iran. Aids 2009, 23(4):538-540.
20. Javadi A., Ataei B., Pourahmad M. The relationship between frequency and duration of imprisonment and the prevalence of HBS Ag, AntiHCV and HIV antibody seropositivity in Iranian prisoners. Journal of Medical Council IRI 2007, 24(4):358-364.
21. Joint United Nations Programme on HIV/AIDS UNAIDS report on the global AIDS epidemic 2010, UNAIDS, Geneva.
22. Khamisipour G.R., Tahmasebi R. Prevalence of HIV, HBV, HCV and syphilis infection in high risk groups of Bushehr province, 1999. Iranian South Medical Journal 2000, 3(1):53-59. (Abstract in English, full text in Persian).
23. Khan K.S., Kunz R., Kleijnen J., Antes G. Systematic review to support evidence-based medicine: How to review and apply findings of healthcare research 2003, The Royal Society of Medicine Press, London.
24. Khani M., Vakili M.M. Prevalence and risk factors of HIV, hepatitis B virus and hepatitis C virus infections in drug addicts among Zanjan prisoners. Archives of Iranian Medicine 2003, 6(1):1-4.
25. Khodabakhshi B., Abbassi A., Fadaee F., Rabiee M. Prevalence and risk factors of HIV, hepatitis B virus and hepatitis C virus infections in drug addicts among Gorgan prisoners. Journal of Medical Science 2007, 7(2):252-254.
26. Khodadadizadeh A., Esmaeili Nadimi A., Hosseini S.H., Shabani shahrbabaki Z. The prevalence of HIV, HBV and HCV in narcotic addicted persons referred to the outpatient clinic of Rafsanjan University of Medical Sciences in 2003. Journal of Rafsanjan University of Medical Sciences 2006, 5(1):23-30. (Abstract in English, full text in Persian).
27. Khorvash F., Fasihi Dastjerdi M., Emami Naeini A.R. Paraclinical disorders and prevalence of viral infections in injection drug users. Paper presented at the 1st National Congress of Infection in Addicts 2008.
28. Lawrinson P., Ali R., Buavirat A., Chiamwongpaet S., Dvoryak S., Habrat B., et al. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. Addiction 2008, 103(9):1484-1492.
29. Malekinejad M., Mohraz M., Akbari G., Khairandish P., Malekafzali H., Rutherford G., et al. HIV and related risk behaviors survey of injecting drug users using Respondent Driven Sampling (RDS) in Tehran, Iran, 2007 2008, Iranian Research Center for HIV/AIDS (IRCHA) & UCSF GLobal Health Sciences, Tehran.
30. Malta M., Magnanini M.M., Mello M.B., Pascom A.R., Linhares Y., Bastos F.I. HIV prevalence among female sex workers, drug users and men who have sex with men in Brazil: A systematic review and meta-analysis. BMC Public Health 2010, 10:317.
31. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S.A., et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet 2008, 10.1016/S0140-6736(08)61311-2.
32. Ministry of Health Islamic Republic of Iran country report on monitoring of the United Nations General Assembly Special Session (UNGASS) on HIV and AIDS, year 2009 2010, Center for Disease Management, Ministry of Health, Tehran.
33. Ministry of Health Current statistics on HIV/AIDS infection in Islamic Republic of Iran 2011, Center for Disease Management, Tehran, (in Persian).
34. Mirahmadizadeh A.R., Kadivar M.R., Ghane Shirazi R., Fararooei M. Prevalence of HIV infection among intravenous drug addicts in Shiraz. Journal of Gorgan University Medical Sciences 2001, 3(8):39-41. (Abstract in English, full text in Persian).
35. Mohammad-Alizadeh A.H., Alavian A.M., Jafari K., Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan, Iran. World Journal of Gastroenterology 2005, 11(26):4058-4089.
36. Mohammadzadeh M., Seif Farshid M., Kousha A. High risk behaviors and HIV prevalence among prisoners of East-Azarbayjan province, 2005. Paper presented at the 3rd National Epidemiology Congress 2006, (in Persian).
37. Mojtahedzadeh V., Razani N., Malekinejad M., Vazirian M., Shoaee S., Saberi Zafarghandi M.B., et al. Injection drug use in rural Iran: Integrating HIV prevention into Iran's rural primary health care system. Aids and Behavior 2008, 12(4 Suppl.):S7-S12.
38. Naghshvarian M., Amini Lari M. Assessing characteristics of addicts refered to a DIC in Shiraz, 2007. Paper presented at the 1st National congress of Infection in Addicts 2008, (in Persian).
39. Rapid situation assessment of drug abuse in Iran (year 2007) 2009, Danjeh Publication, Tehran, (in Persian). H. Narenjiha, H. Rafiei, A.R. Baghestani, R. Nouri, B. Ghafouri, L. Soleimaninia (Eds.).
40. Nazer M.R., Farhoudi F. Soft tissue infections and risk of hospitalization and death among injection drug users. Paper presented at the 1st National congress of Infection in Addicts 2008.
41. Rahbar A., Rooholamini S., Khoshnood K. Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. International Journal of Drug Policy 2004, 15(2):151-155.
42. Rahimi-Movaghar A. A review of the prevalence and the patterns of drug abuse in women in Iran. Social Welfare Quarterly 2004, 12:203-226. (Abstract in English, full text in Persian).
43. Rahimi-Movaghar A., Razaghi E.M., Amin-Esmaeili M., Sahimi-Izadian E. Patterns of sexual behaviours among injection drug users in Tehran, Iran. Paper presented at the IHRA's 20th International conference 2009.
44. Rahimi-Movaghar A., Razaghi E.M., Sahimi-Izadian E., Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. International Journal of Infectious Disease 2010, 14(1):e28-e33.
45. Rahimi-Movaghar A., Vameghi M. Drug addiction. Social situation report in Iran 2011, Rahman Institute, Tehran, (in Persian). S. Madani (Ed.).
46. Razaghi E.M., Rahimi-Movaghar A., Amin-Esmaeili M., Sahimi Izadian E., Baghestani A.R. The study of prevalence of infectious diseases among injecting drug abusers and their correlated factors in Tehran in 2006-2007 2008, Iranian National Center for Addiction Studies, Tehran.
47. Razzaghi E.M., Rahimi-Movaghar A., Green T.C., Khoshnood K. Profiles of risk: A qualitative study of injecting drug users in Tehran, Iran. Harm Reduction Journal 2006, 3(12).
48. Stimson G.V. AIDS and injecting drug use in the United Kingdom, 1987-1993: The policy response and the prevention of the epidemic. Social Science and Medicine 1995, 41(5):699-716.
49. Tajbakhsh E., Yaghubi R. Serologic evaluation of HIV contamination in Shahrekord prisoners through ELISA and Western blot. The Scientific Journal of Iranian Blood Transfusion Organization (SJIBTO) 2008, 4(5 Suppl.):365-368. (in Persian).
50. Talaie H., Shadnia S.H., Okazi A., Pajouhmand A., Hasanian H., Arianpoor H. The prevalence of hepatitis B, hepatitis C and HIV infections in non-IV drug opioid poisoned patients in Tehran, Iran. Pakistan Journal of Biological Science 2007, 10(2):220-224.
51. United Nation Office on Drugs and Crime World drug report 2010 2010, UNODC, Vienna.
52. Vahdani P., Hosseini-Moghaddam S.M.M., GachKar L., Sharafi K. Prevalence of hepatitis B, hepatitis C, human immunodeficiency virus, and syphilis among street children residing in southern Tehran, Iran. Archives of Iranian Medicine 2006, 9(2):153-155.
53. World Health Organisation Advocacy guide: HIV/AIDS prevention among injecting users 2004, World Health Organization, UNAIDS, Geneva.
54. World Health Organisation WHO, UNODC, UNAIDS Technical Guide for countries to set targets for universal access to HIV prevention treatment and care for injecting drug users 2009, WHO, Geneva.
55. Yasami M.T., Shahmohammadi D., Naghavi M., Bagheri-Yazdi A., Zojaji A., Rahimi-Movaghar A., et al. Epidemiology of drug abuse in I.R. Iran 2002, Ministry of Health and Drug Control Headquarters, Tehran.
56. Zamani S., Kihara M., Gouya M.M., Vazirian M., Nassirimanesh B., Ono-Kihara M., et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. Journal of Acquired Immune Deficiency Syndrome 2006, 42(3):342-346.
57. Zamani S., Kihara M., Gouya M.M., Vazirian M., Ono-Kihara M., Razzaghi E.M., et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS 2005, 19(7):709-716.